Back to Search Start Over

301MO Genomic HLA as a predictive biomarker for survival among non-small cell lung cancer patient treated with single agent immunotherapy

Authors :
Abed, A.
Calapre, L.
Lo, J.
Correia, S.
Bowyer, S.
Chopra, A.
Watson, M.
Khattak, M.
Millward, M.
Gray, E.
Abed, A.
Calapre, L.
Lo, J.
Correia, S.
Bowyer, S.
Chopra, A.
Watson, M.
Khattak, M.
Millward, M.
Gray, E.
Source :
Abed, A., Calapre, L., Lo, J., Correia, S., Bowyer, S., Chopra, A. <
Publication Year :
2020

Abstract

We aimed to assess the role of genomic HLA-I/II homozygosity in the overall survival benefit in patients with unresectable locally advanced, metastatic non-small lung cancer treated by single agent PD1/PDL1 inhibitors...

Details

Database :
OAIster
Journal :
Abed, A., Calapre, L., Lo, J., Correia, S., Bowyer, S., Chopra, A. <
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1260266831
Document Type :
Electronic Resource